Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares ...

CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The ...

Apple (NASDAQ: AAPL) stock fell 0.5% after Jefferies said that latest indications suggest that demand for the iPhone 16 ...

A federal antitrust watchdog is conducting an investigation into, and has filed suit against, huge pharmacy middlemen. Two ...

A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...

CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.

The Woonsocket, R.I.-based health care giant said it would cut more than 100 positions in January at its corporate office in ...

UnitedHealth Group and CVS Health are asking FTC commissioners to recuse themselves from a case against pharmacy benefit ...

As CVS Health lays off more than 400 positions connected to its offices in Hartford, state officials have several initiatives ...

Looking for undervalued stocks? Here are the top undervalued stocks in November 2024. Check out the list here.

Pharmacy chains are in crisis ...